David E. I. Pyott is now serving in a new board position at Pliant Therapeutics, Inc.
Jan 15, 2021
Board and Executive Moves
President at International Council of Ophthalmology Foundation
In The News
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 16, 2021 - GlobeNewswire
Pioneering General Counsel Mary Ann Hynes to host a candid Vanguard Network discussion on "My 3 Biggest Mistakes That Have Made Me a Better Leader"; Sometimes the greatest learnings come the hard way. Longtime GC Mary Ann Hynes shares hers in an intimate,
Mar 09, 2021 - PR Newswire
Mar 08, 2021 - PRWeb
Pliant Therapeutics, Inc. engages in the business of developing and commercializing novel therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. Pliant Therapeutics was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
In The News
Feb 18, 2021 - GlobeNewswire
Jan 15, 2021 - RelSci
Jan 12, 2021 - GlobeNewswire